中文 / CN
Deutsch / DE
日本語 / JP
한글 / KR
Contact Us
菜单
Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Company

Vision
& Mission

Our Vision

“Every drug can be made and every disease can be treated” by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry

Our Mission

To accelerate and transform the discovery, development and manufacturing of biologics through a comprehensive open-access platform, enabling our global healthcare partners and benefiting patients worldwide

Our Company

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

 

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2023, WuXi Biologics is supporting 621 integrated client projects, including 22 in commercial manufacturing.

 

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.

As of Jun 30, 2023
286

projects in pre-clinical development stage

269

projects in early-phase clinical trials

44

projects in late-phase clinical trials

22

projects in commercial manufacturing

WuXi Biologics Corporate Brochure

PROUD Culture

  • P: Passion

    Customer focus
    Positive attitude and energy
    Continuous learning

  • R: Reward

    Tackling tough tasks
    Embracing change
    Giving back to society

  • O: Ownership

    Accountability
    Excellence and efficiency
    Honesty and Ethics

  • U: Unity

    Diversity and inclusion
    Respect and communication
    Teamwork

  • D: Determination

    Strong execution
    GROWTH mindset
    Calculated risks

  • Learn more

History & Awards

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

Business Ethics & IP Policy

As a leading global open-access biologics technology platform, WuXi Biologics is committed to the highest standards of ethics and integrity. Employees, officers and directors strive to deal honestly, ethically and fairly with our suppliers, customers, competitors, employees and the communities we serve worldwide. Statements regarding the Company’s products and services must not be false, misleading, deceptive or fraudulent. WuXi Biologics strives to conduct business with individuals and organizations who share our commitment to highest ethical standards and who operate in a socially and environmentally responsible manner.. 

In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel. Compliance reporting: IA_biologics@wuxibiologics.com，Compliance_Biologics@wuxibiologics.com

《Anti-Corruption Policy of WuXi Biologics》 《WHISTLEBLOWING AND INVESTIGATION》 《THE CONFLICT OF INTEREST POLICY》

《CODE OF BUSINESS CONDUCT AND ETHICS》 《CODE OF BUSINESS CONDUCT AND ETHICS of WuXi Biologics Business Partner》

Preservation of your IP is our highest priority.
We have established stringent policies and procedures for IP protection and prosecution of IP violations to ensure your success and win your trust.

“Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.”

- Dr. Ge Li, Chairman of WuXi Biologics

Intellectual Property Protection is the foundation of trust between WuXi Biologics and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for prosecution of IP violations. We guard IP with founding principles of integrity, world-class security, zero-tolerance policy enforcement, and relentless pursuit of justice against any criminal act.


Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?

Yes, continue to proceed
No, stay on this Website